# Nasospore Stent For Use in Enodscopic Sinus Surgery

> **NCT00671541** · PHASE4 · WITHDRAWN · sponsor: **Lahey Clinic**

## Conditions studied

- Chronic Sinusitis

## Interventions

- **DRUG:** Merogel Nasal Stent and Nasopore Stent
- **DRUG:** Nasopore Stent and either Gentamycin or Bacitracin

## Key facts

- **NCT ID:** NCT00671541
- **Lead sponsor:** Lahey Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-03
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Principal Investigator left the institution requested study terminated.
- **Last updated:** 2012-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00671541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00671541, "Nasospore Stent For Use in Enodscopic Sinus Surgery". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00671541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*